APA (7th ed.) Citation

DL, O., SJ, F., S, S., A, F., L, B., E, P., . . . JT, G. (2023). Discovery and characterization of orally bioavailable 4-chloro-6-fluoroisophthalamides as covalent PPARG inverse-agonists. Bioorganic & medicinal chemistry, 78, 117130. https://doi.org/10.1016/j.bmc.2022.117130

Chicago Style (17th ed.) Citation

DL, Orsi, et al. "Discovery and Characterization of Orally Bioavailable 4-chloro-6-fluoroisophthalamides as Covalent PPARG Inverse-agonists." Bioorganic & Medicinal Chemistry 78 (2023): 117130. https://doi.org/10.1016/j.bmc.2022.117130.

MLA (9th ed.) Citation

DL, Orsi, et al. "Discovery and Characterization of Orally Bioavailable 4-chloro-6-fluoroisophthalamides as Covalent PPARG Inverse-agonists." Bioorganic & Medicinal Chemistry, vol. 78, 2023, p. 117130, https://doi.org/10.1016/j.bmc.2022.117130.